Phosphodiesterase 4D mRNA (PDE4D mRNA) (PDE4D mRNA)

Phosphodiesterase 4D (PDE4D) mRNA is the messenger RNA transcript that encodes the PDE4D enzyme, a member of the cyclic nucleotide phosphodiesterase family that specifically hydrolyzes cyclic adenosine monophosphate (cAMP) (UniProt: Q08499). By regulating cAMP levels, PDE4D plays a pivotal role in intracellular signaling pathways associated with synaptic plasticity, memory, and inflammatory responses (NCBI Gene: 5144). Targeting the mRNA transcript directly using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) provides a mechanism to selectively reduce PDE4D protein expression, which is a therapeutic strategy for treating neurodegenerative diseases like Alzheimer's and vascular conditions such as ischemic stroke (PubMed: PMID 25630773). This approach is particularly attractive because it may offer greater specificity than traditional small-molecule inhibitors, potentially avoiding the dose-limiting side effects like emesis that are common with systemic PDE4 inhibition. Elevated expression or specific genetic variants of PDE4D have been linked to an increased risk of stroke and cognitive decline, making the mRNA a high-priority target for precision medicine (PubMed: PMID 12891558). Current therapeutic development focuses on optimizing the delivery of these nucleic acid-based drugs to the brain and lungs to maximize efficacy while minimizing off-target hybridization.

Other names

cAMP-specific 3',5'-cyclic phosphodiesterase 4D mRNADPDE3 mRNASTRK1 mRNAHSPDE4D1 mRNAPhosphodiesterase 4D transcript

RNase H-mediated degradation of mRNA or RNA interference (RNAi) to inhibit translation and reduce PDE4D protein levels.